Clinical Trial Update: A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia [Phase 3]

View source ↗

Summary

A Phase III, randomized trial evaluating combination therapy with calcium-based phosphate binders for hyperphosphatemia in chronic kidney disease patients has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperphosphatemia

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Chronic Kidney Disease, Dialysis | Phase 3 | Status: TERMINATED